Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309217 · ClinicalTrials.gov registry record · Phase 4
Dissemination of Tobacco Tactics for Hospitalized Smokers
A Phase 4 study of Smoking Cessation, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,528
- Enrollment target
- 6
- Study locations
NCT01309217 is a Phase 4 study of Smoking Cessation that has completed, run by University of Michigan. The registered enrollment target is 1,528 participants, above the 467-participant average among 188 other Smoking Cessation trials with a reported enrollment target (227% higher). The trial reports 6 study locations across 1 state.
The verdict
NCT01309217, a Phase 4 study of Smoking Cessation, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,528 participants
- Enrollment target
- 6
- Study locations
Study Summary
Nurse-administered smoking cessation interventions have been shown to be efficacious, but are seldom implemented due to lack of training and time. This project aims to disseminate and test the nurse-administered Tobacco Tactics intervention in 6 hospitals.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Tobacco Tactics Intervention
Study Locations (6)
Michigan
- Saint Mary's Healthcare - Grand Rapids
- St. Mary Mercy - Livonia
- Mercy Health Partners - Hackley Campus - Muskegon
- Mercy Health Partners - Mercy Campus - Muskegon
- St. Joseph Mercy - Oakland
- St. Joseph Mercy Hospital - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,528 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01309217
The ClinicalTrials.gov registry entry for NCT01309217 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,528 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 467-participant average among 188 other Smoking Cessation trials with a reported enrollment target (227% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT01309217 reports 6 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01309217 about?
NCT01309217 is a clinical study titled "Dissemination of Tobacco Tactics for Hospitalized Smokers". Nurse-administered smoking cessation interventions have been shown to be efficacious, but are seldom implemented due to lack of training and time. This project aims to disseminate and test the nurse-administered Tobacco Tactics intervention in 6 hospitals.
What is the current status of trial NCT01309217?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,528 participants. The study started on 2011-07. Estimated completion is 2014-03.
What conditions does trial NCT01309217 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01309217?
The interventions under investigation include: Usual Care (OTHER), Tobacco Tactics Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01309217?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01309217 being conducted?
This trial has 6 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.